NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept back onto his 5-foot-5-inch frame. A little over a year ago, the 58-year-old Manhattan resident went on a new weight loss drug called Wegovy. He’s lost 30 pounds, and has started eating healthier food and exercising — the habits behind many commercial diet plans and decades of conventional wisdom on sustainable weight loss. Yet Jobling’s experience also has altered his perspective on dieting. He now sees obesity as a disease that requires medical intervention, not just behavioral changes. In fact, he thinks he will need to stay on a drug like Wegovy for the rest of his life even though it has taken some of the joy out of eating. |
Canadian teen at McDonald's driveUS move of tariff hikes sets 'bad example' for free tradeUN official dismisses allegation of 'overcapacity' in China's green industries as misplacedUMass Dartmouth's billionaire commencement speaker stuns graduates by giving them each $1,000Chinese cultural performances, languageBoost for borrowers as three major UK banks reduce their mortgage ratesAustralia to host 2026 AFC Women's Asian CupGreenwood won't return to Man Utd, says Getafe presidentChinese cultural performances, languageOlympic flame arrives in Marseille amid tight security